Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High energy shock waves do not affect either primary tumor growth or metastasis of prostate carcinoma, R3327-MatLyLu.

Literature DB >> 2922893

High energy shock waves do not affect either primary tumor growth or metastasis of prostate carcinoma, R3327-MatLyLu.

Abstract

We investigated the possibility that extracorporeal high energy shock wave (HESW) treatment of solid tumors increased metastatic tumor cell spread using a rapidly metastasising rat prostate tumor variant (R3327-MatLyLu). Volume of HESW treated primary tumor, the volume of metastatic lymph nodes and the number of lung tumor nodules formed were compared with values in untreated control rats. HESW treatment resulted in marked hemorrhage and readily visible hematoma at the focal point of treatment. Tumor histology directly after treatment showed extravascular blood cells due to breakage of blood vessels. Contrary to previous reports we could not observe a delay in tumor growth rate in either small or medium sized tumors. More importantly the extent of metastatic spread was not influenced by HESW treatment.

Entities: Disease Species

Mesh：

Year: 1989 PMID： 2922893 DOI： 10.1007/BF00261041

Source DB: PubMed Journal: Urol Res ISSN： 0300-5623

10 in total

1. Extracorporeal shock wave lithotripsy and its effect on renal function.

Authors: B R Gilbert; R A Riehle; E D Vaughan
Journal: J Urol Date: 1988-03 Impact factor: 7.450

2. Histopathologic and ultrastructural correlates of tumor growth suppression by high energy shock waves.

Authors: P Russo; C Mies; R Huryk; W D Heston; W R Fair
Journal: J Urol Date: 1987-02 Impact factor: 7.450

3. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.

Authors: P Janik; P Briand; N R Hartmann
Journal: Cancer Res Date: 1975-12 Impact factor: 12.701

4. Development of an in vivo clonogenic cell assay for rat prostate metastatic tumor--R3327-MatLyLu.

Authors: A A Geldof; B R Rao; H J de Voogt
Journal: Urol Res Date: 1987

5. Extracorporeal shock-wave lithotripsy for upper urinary tract calculi. One year's experience at a single center.

Authors: R A Riehle; W R Fair; E D Vaughan
Journal: JAMA Date: 1986-04-18 Impact factor: 56.272

6. Free radical production by high energy shock waves--comparison with ionizing irradiation.

Authors: T R Morgan; V P Laudone; W D Heston; L Zeitz; W R Fair
Journal: J Urol Date: 1988-01 Impact factor: 7.450

7. Doxorubicin treatment increases metastasis of prostate tumor (R3327-MatLyLu).

Authors: A A Geldof; B R Rao
Journal: Anticancer Res Date: 1988 Nov-Dec Impact factor: 2.480

8. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.

Authors: B Fisher; N Gunduz; E A Saffer
Journal: Cancer Res Date: 1983-04 Impact factor: 12.701

9. Extracorporeally induced destruction of kidney stones by shock waves.

Authors: C Chaussy; W Brendel; E Schmiedt
Journal: Lancet Date: 1980-12-13 Impact factor: 79.321

10. High energy shock waves suppress tumor growth in vitro and in vivo.

Authors: P Russo; R A Stephenson; C Mies; R Huryk; W D Heston; M R Melamed; W R Fair
Journal: J Urol Date: 1986-03 Impact factor: 7.450

10 in total

6 in total

Review 1. Section 8--clinical relevance. American Institute of Ultrasound in Medicine.

Authors:
Journal: J Ultrasound Med Date: 2000-02 Impact factor: 2.153

Review 2. Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.

Authors:
Journal: J Ultrasound Med Date: 2000-02 Impact factor: 2.153

Review 3. Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine.

Authors:
Journal: J Ultrasound Med Date: 2000-02 Impact factor: 2.153

High energy shock waves do not affect either primary tumor growth or metastasis of prostate carcinoma, R3327-MatLyLu.

1. Extracorporeal shock wave lithotripsy and its effect on renal function.

2. Histopathologic and ultrastructural correlates of tumor growth suppression by high energy shock waves.

3. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.

4. Development of an in vivo clonogenic cell assay for rat prostate metastatic tumor--R3327-MatLyLu.

5. Extracorporeal shock-wave lithotripsy for upper urinary tract calculi. One year's experience at a single center.

6. Free radical production by high energy shock waves--comparison with ionizing irradiation.

7. Doxorubicin treatment increases metastasis of prostate tumor (R3327-MatLyLu).

8. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.

9. Extracorporeally induced destruction of kidney stones by shock waves.

10. High energy shock waves suppress tumor growth in vitro and in vivo.

Review 1. Section 8--clinical relevance. American Institute of Ultrasound in Medicine.

Review 2. Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.

Review 3. Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine.

Review 4. Section 4--bioeffects in tissues with gas bodies. American Institute of Ultrasound in Medicine.

5. Tumor therapy with shock waves requires modified lithotripter shock waves.

6. Histotripsy: the first noninvasive, non-ionizing, non-thermal ablation technique based on ultrasound.